MSCI Q2 Earnings Beat Estimates, Revenues Rise Y/Y, Shares Fall — Neutral

MSCI   Zacks Investment Research — July 22, 2025

MSCI posts strong second-quarter 2025 earnings and revenue growth, but shares slip despite higher recurring and asset-based fees.

image for news MSCI Q2 Earnings Beat Estimates, Revenues Rise Y/Y, Shares Fall

Buy, Hold or Sell UPS Stock? Key Tips Ahead of Q2 Earnings — Negative

UPS   Zacks Investment Research — July 22, 2025

United Parcel Service braces for Q2 headwinds with falling volumes and rising labor costs. The 26% stock drop over the past six months adds to its woes.

image for news Buy, Hold or Sell UPS Stock? Key Tips Ahead of Q2 Earnings

Palantir Bulls and Bears Set for an August Showdown — Positive

PLTR   MarketBeat — July 22, 2025

Palantir Technologies Inc. NASDAQ: PLTR continues to exceed expectations. As of July 21, the stock was up 102% in 2025.

image for news Palantir Bulls and Bears Set for an August Showdown

EVEX vs. JOBY: Which eVTOL Stock Holds the Edge in Urban Air Mobility? — Neutral

EVEX  JOBY   Zacks Investment Research — July 22, 2025

Eve Holding edges out Joby Aviation in the eVTOL race with strong LOIs, better earnings surprise history, and Embraer support.

image for news EVEX vs. JOBY: Which eVTOL Stock Holds the Edge in Urban Air Mobility?

Hims & Hers Paves the Way for Global Digital Health Expansion — Positive

HIMS   Zacks Investment Research — July 22, 2025

HIMS accelerates its global push with the ZAVA acquisition and a planned Canada launch targeting affordable obesity care.

image for news Hims & Hers Paves the Way for Global Digital Health Expansion

Sarepta Therapeutics' recent setbacks and restructuring have pressured Arrowhead's share price due to concerns over milestone payments and clinical program continuity. Arrowhead's financial position remains strong, even with a reduced runway caused by the lack of promised milestone payments from Sarepta. In today's article, I discuss a range of potential outcomes for the collaboration between Sarepta Therapeutics and Arrowhead Pharmaceuticals and what Arrowhead can do with its pipeline and financials.

image for news How The Negative Developments At Sarepta Therapeutics Impact Arrowhead Pharmaceuticals

First BanCorp. (FBP) Q2 2025 Earnings Call Transcript — Neutral

FBP   Seeking Alpha — July 22, 2025

First BanCorp. (NYSE:FBP ) Q2 2025 Earnings Conference Call July 22, 2025 10:00 AM ET Company Participants Ramon Rodriguez - Senior Vice President of Corporate Strategy / Investor Relations Aurelio Aleman-Bermudez - President, CEO & Director Orlando Berges-González - Executive VP & CFO Conference Call Participants Brett D. Rabatin - Hovde Group, LLC, Research Division Timur Felixovich Braziler - Wells Fargo Securities, LLC, Research Division Kelly Ann Motta - Keefe, Bruyette, & Woods, Inc., Research Division Operator Hello, and welcome, everyone, to the First BanCorp 2Q 2025 Financial Results.

image for news First BanCorp. (FBP) Q2 2025 Earnings Call Transcript

DURHAM, N.C., July 22, 2025 (GLOBE NEWSWIRE) -- Aspida Life Re Ltd (“Aspida Re”), a Bermuda-based life and annuity reinsurance company, announced the execution of its second reinsurance transaction in Japan, effective June 1, 2025. This milestone marks a significant step in Aspida Re's ongoing strategy to expand its global footprint and deliver innovative reinsurance solutions to life and annuity insurance partners worldwide.

image for news Aspida Re Expands Global Footprint with Strategic Reinsurance Transaction in Japan

Avery Dennison Corporation (NYSE:AVY ) Q2 2025 Earnings Call July 22, 2025 11:00 AM ET Company Participants s - Corporate Participant e - Corporate Participant d - Corporate Participant Deon M. Stander - President, CEO & Director Gregory S.

image for news Avery Dennison Corporation (AVY) Q2 2025 Earnings Conference Call Transcript

Step Aside Magnificent 7! These Fortunate 3 Stocks are The New Market Leaders — Positive

NFLX  PLTR  UBER   24/7 Wall Street — July 22, 2025

The Magnificent Seven group of tech stocks, as a whole, may still be fantastic long-term bets.

image for news Step Aside Magnificent 7! These Fortunate 3 Stocks are The New Market Leaders

BOK Financial's Q2 Earnings Beat on NII & Loan Growth, Stock Gains — Positive

BOKF   Zacks Investment Research — July 22, 2025

BOKF beats Q2 estimates as net interest income and loan growth lift results, despite rising costs and weaker deposits.

image for news BOK Financial's Q2 Earnings Beat on NII & Loan Growth, Stock Gains

Strategy vs. Riot Platforms: Which Bitcoin-Focused Stock Has an Edge? — Positive

MSTR  RIOT   Zacks Investment Research — July 22, 2025

The increasing acceptance of Bitcoin as a store of value benefits MSTR and RIOT. Find out which stock is leading now.

image for news Strategy vs. Riot Platforms: Which Bitcoin-Focused Stock Has an Edge?

CRWD Bets on Agentic AI Security: Will it Unlock Next Growth Phase? — Positive

CRWD   Zacks Investment Research — July 22, 2025

CrowdStrike deepens its AI security focus with new agentic tools and AWS ties.

image for news CRWD Bets on Agentic AI Security: Will it Unlock Next Growth Phase?

Neils Christensen has a diploma in journalism from Lethbridge College and has more than a decade of reporting experience working for news organizations throughout Canada. His experiences include covering territorial and federal politics in Nunavut, Canada.

image for news From tax reform to gold reserves: states lead the charge for sound money

Invesco Ltd. (IVZ) Q2 2025 Earnings Conference Call Transcript — Neutral

IVZ   Seeking Alpha — July 22, 2025

Invesco Ltd. (NYSE:IVZ ) Q2 2025 Earnings Call July 22, 2025 9:00 AM ET Company Participants Andrew Ryan Schlossberg - President, CEO & Director Gregory Wade Ketron - Head of Investor Relations & Treasury Laura Allison Dukes - Senior MD & CFO Conference Call Participants Alexander Blostein - Goldman Sachs Group, Inc., Research Division Benjamin Elliot Budish - Barclays Bank PLC, Research Division Brian Bertram Bedell - Deutsche Bank AG, Research Division Glenn Paul Schorr - Evercore ISI Institutional Equities, Research Division Kenneth Brooks Worthington - JPMorgan Chase & Co, Research Division Michael J.

image for news Invesco Ltd. (IVZ) Q2 2025 Earnings Conference Call Transcript

Interpublic Group Earnings Beat Estimates in Q2, Revenues Slide Y/Y — Neutral

IPG   Zacks Investment Research — July 22, 2025

IPG posts 23% y/y EPS growth in second-quarter 2025. Yet, revenues slip 6.7% and margins face sharp y/y declines.

image for news Interpublic Group Earnings Beat Estimates in Q2, Revenues Slide Y/Y

Earnings Estimates Moving Higher for Fulton Financial (FULT): Time to Buy? — Positive

FULT   Zacks Investment Research — July 22, 2025

Fulton Financial (FULT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

image for news Earnings Estimates Moving Higher for Fulton Financial (FULT): Time to Buy?

Why Interactive Brokers (IBKR) Might be Well Poised for a Surge — Positive

IBKR   Zacks Investment Research — July 22, 2025

Interactive Brokers Group, Inc. (IBKR) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

image for news Why Interactive Brokers (IBKR) Might be Well Poised for a Surge

Earnings Estimates Moving Higher for Charles Schwab (SCHW): Time to Buy? — Positive

SCHW   Zacks Investment Research — July 22, 2025

The Charles Schwab Corporation (SCHW) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

image for news Earnings Estimates Moving Higher for Charles Schwab (SCHW): Time to Buy?

The company ORCL-2.37% is helping OpenAI boost its artificial-intelligence data-center capacity, and analysts at Evercore ISI are doing the math about how much that will cost Oracle as it pursues the potential for $30 billion in annualized revenue down the road.

image for news As Oracle's stock falls after Stargate developments, here's one big question for investors